The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment

Mario F Juruena, Anthony J Cleare, Andrew S Papadopoulos, Lucia Poon, Stafford Lightman, Carmine M Pariante

Research output: Contribution to journalArticle (Academic Journal)peer-review

Abstract

Depressed patients have reduced glucocorticoid receptor (GR) function, as demonstrated by resistance to the suppressive effects of the synthetic glucocorticoid hormone, and GR agonist, dexamethasone. We have developed a suppressive test with prednisolone, a synthetic glucocorticoid that is similar to cortisol in its pharmacodynamics and pharmacokinetics, and binds to both the GR and the mineralocorticoid receptor (MR). We have found that depressed patients suppress normally to prednisolone, unless they are particularly non-responsive to treatment. In the present study, we evaluated 28 inpatients with treatment-resistant depression (TRD), and compared salivary cortisol secretion (at 0900 h, 1200 h and 1700 h) after placebo or after prednisolone (5 mg), before and after an inpatient treatment admission. Half of the patients (n=14) reached treatment response. When comparing the assessment between admission and discharge, cortisol output after placebo fell (-26% of area under the curve; p=0.024) while the output after prednisolone did not change. Moreover, there was no change in the response to prednisolone (percentage suppression) between admission at discharge, and this was not influenced by treatment response. Finally, we could confirm and extend our previously published data with prednisolone (5 mg), showing that depressed patients (n=12) and controls (n=12) suppressed equally to both 5 and 10 mg doses of prednisolone. This study suggests that the response to prednisolone is similar in depressed patients and controls at different doses of prednisolone, and does not change with symptomatic improvement. This is in contrast with findings, from us and others, using other measures of hypothalamic-pituitary-adrenal axis function, such as basal cortisol levels or the response to dexamethasone. Thus, we propose that the prednisolone suppression test may offer specific biological and clinical information, related to its action at both the GR and the MR.

Original languageEnglish
Pages (from-to)1486-91
Number of pages6
JournalPsychoneuroendocrinology
Volume35
Issue number10
DOIs
Publication statusPublished - Nov 2010

Bibliographical note

Copyright © 2010 Elsevier Ltd. All rights reserved.

Keywords

  • Antidepressive Agents/therapeutic use
  • Depressive Disorder, Major/diagnosis
  • Dose-Response Relationship, Drug
  • Female
  • Glucocorticoids/administration & dosage
  • Humans
  • Inpatients
  • Linear Models
  • Male
  • Middle Aged
  • Prednisolone/administration & dosage
  • Psychiatric Status Rating Scales
  • Saliva/metabolism

Fingerprint

Dive into the research topics of 'The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment'. Together they form a unique fingerprint.

Cite this